criteria_sentences
clinically known or suspected history of secondary hypertension
dislipidemia or hypertension due to secondary causes
evidence of a secondary form of hypertension
evidence of a secondary form of hypertension ; including but not limited to any of the following :
evidence of a secondary form of hypertension ; including but not limited to any of the following :
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; including but not limited to any of the following : coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease .
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; etc
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma ; polycystic kidney disease etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery stenosis ; or pheochromocytoma ; etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery stenosis ; or pheochromocytoma ; etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery stenosis ; or pheochromocytoma ; etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery stenosis ; or pheochromocytoma ; etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery stenosis ; or pheochromocytoma ; etc .
evidence of a secondary form of hypertension ; such as coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery stenosis ; or pheochromocytoma ; etc .
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma .
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma .
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma .
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma .
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma .
evidence of a secondary form of hypertension ; to include coarctation of the aorta ; primary hyperaldosteronism ; renal artery stenosis ; or pheochromocytoma .
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ( coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing disease ; pheochromocytoma or polycystic kidney disease )
evidence of secondary form of hypertension ; including coarctation of the aorta ; hyperaldosteronism ; renal artery stenosis or pheochromocytoma
evidence of secondary form of hypertension ; including coarctation of the aorta ; hyperaldosteronism ; renal artery stenosis or pheochromocytoma
evidence of secondary form of hypertension ; including coarctation of the aorta ; hyperaldosteronism ; renal artery stenosis or pheochromocytoma
evidence of secondary form of hypertension ; including coarctation of the aorta ; hyperaldosteronism ; renal artery stenosis or pheochromocytoma
evidence of secondary form of hypertension ; including coarctation of the aorta ; hyperaldosteronism ; renal artery stenosis or pheochromocytoma
evidence of secondary form of hypertension ; including coarctation of the aorta ; hyperaldosteronism ; renal artery stenosis or pheochromocytoma
has secondary hypertension of any etiology ( eg ; renovascular disease ; pheochromocytoma ; cushing syndrome ) .
has secondary hypertension of any etiology ( eg ; renovascular disease ; pheochromocytoma ; cushing syndrome ) .
has secondary hypertension of any etiology ( eg ; renovascular disease ; pheochromocytoma ; cushing syndrome ) .
history of secondary hypertension ( including primary aldosteronism ; renovascular hypertension ; pheochromocytoma ; etc ; ) .
history of secondary hypertension ( including primary aldosteronism ; renovascular hypertension ; pheochromocytoma ; etc ; ) .
history of secondary hypertension ( including primary aldosteronism ; renovascular hypertension ; pheochromocytoma ; etc ; ) .
history of secondary hypertension ( including primary aldosteronism ; renovascular hypertension ; pheochromocytoma etc ; )
history of secondary hypertension ( including primary aldosteronism ; renovascular hypertension ; pheochromocytoma etc ; )
history of secondary hypertension ( including primary aldosteronism ; renovascular hypertension ; pheochromocytoma etc ; )
history of secondary hypertension including renal disease ; pheochromocytoma ; or cushing syndrome .
history of secondary hypertension including renal disease ; pheochromocytoma ; or cushing syndrome .
history of secondary hypertension including renal disease ; pheochromocytoma ; or cushing syndrome .
history or evidence of a secondary form of hypertension
history or evidence of a secondary form of hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ; and drug-induced hypertension .
history or evidence of a secondary form of hypertension ; including but not limited to any of the following : renal parenchymal hypertension ; renovascular hypertension ( unilateral renal artery or bilateral renal artery stenosis ) ; coarctation of the aorta ; primary hyperaldosteronism ; cushing disease ; pheochromocytoma ; polycystic kidney disease ( pkd ) ; drug-induced hypertension
history or evidence of a secondary hypertension
history or evidence of a secondary hypertension of any etiology ( eg ; uncorrected renal artery stenosis ; pheochromocytoma ) .
history or evidence of a secondary hypertension of any etiology ( eg ; uncorrected renal artery stenosis ; pheochromocytoma ) .
history or evidence of a secondary hypertension of any etiology ( eg ; uncorrected renal artery stenosis ; pheochromocytoma ) .
history or evidence of secondary form of hypertension
history or evidence of secondary form of hypertension .
history or evidence of secondary hypertension of any etiology ( eg ; uncorrected renal artery stenosis ; pheochromocytoma ) .
history or evidence of secondary hypertension of any etiology ( eg ; uncorrected renal artery stenosis ; pheochromocytoma ) .
known or suspected secondary hypertension ( eg ; coarctation of aorta ; renovascular stenosis ; etc ; )
known or suspected secondary hypertension ( eg ; coarctation of aorta ; renovascular stenosis ; etc ; )
known or suspected secondary hypertension ( eg ; coarctation of aorta ; renovascular stenosis ; etc ; )
known or suspected secondary hypertension ( eg ; coarctation of aorta ; renovascular stenosis ; etc ; )
known or suspected secondary hypertension ( eg ; renal artery stenosis ; phaeochromocytoma )
known or suspected secondary hypertension ( eg ; renal artery stenosis ; phaeochromocytoma )
known or suspected secondary hypertension ( eg ; renal artery stenosis orphaeochromocytoma )
known or suspected secondary hypertension ( eg ; renal artery stenosis orphaeochromocytoma )
known or suspected secondary hypertension ( ie ; pheochromocytoma ) .
known or suspected secondary hypertension ( ie ; pheochromocytoma ) .
known or suspected secondary hypertension .
known or suspected secondary hypertension ;
known secondary hypertension of any aetiology ( eg ; uncorrected renal artery stenosis ; malignant hypertension ; or hypertensive encephalopathy )
known secondary hypertension of any aetiology ( eg ; uncorrected renal artery stenosis ; malignant hypertension ; or hypertensive encephalopathy )
known secondary hypertension of any aetiology ( eg ; uncorrected renal artery stenosis ; malignant hypertension ; or hypertensive encephalopathy )
known secondary hypertension of any aetiology ( eg ; uncorrected renal artery stenosis ; malignant hypertension ; or hypertensive encephalopathy )
known secondary hypertension of any etiology ( eg ; uncorrected renal artery stenosis ) .
known secondary hypertension of any etiology ( eg ; uncorrected renal artery stenosis ) .
has secondary hypertension
has secondary hypertension of any etiology ( eg ; renovascular disease ; pheochromocytoma ; cushing syndrome ) .
has secondary hypertension of any etiology .
history of secondary hypertension ( including primary aldosteronism ; renovascular hypertension ; pheochromocytoma ; etc ; ) .
history of secondary hypertension ( including primary aldosteronism ; renovascular hypertension ; pheochromocytoma etc ; )
history of secondary hypertension .
history of secondary hypertension including renal disease ; pheochromocytoma ; or cushing syndrome .
history of secondary hypertension or history of any of the diseases suspected of secondary hypertension
history or evidence of secondary hypertension of any etiology ( eg ; uncorrected renal artery stenosis ; pheochromocytoma ) .
history or evidence of secondary hypertension of any etiology .
known or suspected causes of secondary hypertension
known or suspected secondary hyperlipidemia of any etiology
known or suspected secondary hypertension
other included evidence of secondary hypertension or history of cardio-vascular disease .
other included evidence of secondary hypertension or history of cardio-vascular disease .
patients with history or evidence of a secondary form of hypertension
patients with known or suspect secondary hypertension
patients with known or suspected secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with known severe ( world health organization ( who ) stage iii ; sitting dbp stable at greater than or equal to 110 mmhg ) ; malignant hypertension or secondary hypertension
patients with or suspected of having secondary hypertension ( due to aortic coarctation ; primary aldosteronism ; etc ; )
patients with or suspected of having secondary hypertension ( due to aortic coarctation ; primary aldosteronism ; etc ; )
patients with or suspected of having secondary hypertension ( due to aortic coarctation ; primary aldosteronism ; etc ; )
patients with secondary hypertension or hypertensive emergency such as malignant hypertension .
patients with secondary hypertension or hypertensive emergency such as malignant hypertension .
patients with secondary hypertension or hypertensive emergency such as malignant hypertension .
patients with secondary hypertension or suspected of having secondary hypertension .
screening time ( visit 1 ) ; time of randomization ( visit 2 ) : sitdbp > = 120 mmhg ; patients with secondary blood pressure or suspected of secondary blood pressure ( for example ; aortic coarctation ; primary aldosteronism ; renal artery stenosis ; pheochromocytoma )
screening time ( visit 1 ) ; time of randomization ( visit 2 ) : sitdbp > = 120 mmhg ; patients with secondary blood pressure or suspected of secondary blood pressure ( for example ; aortic coarctation ; primary aldosteronism ; renal artery stenosis ; pheochromocytoma )
screening time ( visit 1 ) ; time of randomization ( visit 2 ) : sitdbp > = 120 mmhg ; patients with secondary blood pressure or suspected of secondary blood pressure ( for example ; aortic coarctation ; primary aldosteronism ; renal artery stenosis ; pheochromocytoma )
screening time ( visit 1 ) ; time of randomization ( visit 2 ) : sitdbp > = 120 mmhg ; patients with secondary blood pressure or suspected of secondary blood pressure ( for example ; aortic coarctation ; primary aldosteronism ; renal artery stenosis ; pheochromocytoma )
screening time ( visit 1 ) ; time of randomization ( visit 2 ) : sitdbp > = 120 mmhg ; patients with secondary blood pressure or suspected of secondary blood pressure ( for example ; aortic coarctation ; primary aldosteronism ; renal artery stenosis ; pheochromocytoma )
screening time ( visit 1 ) ; time of randomization ( visit 2 ) : sitdbp > = 120 mmhg ; patients with secondary blood pressure or suspected of secondary blood pressure ( for example ; aortic coarctation ; primary aldosteronism ; renal artery stenosis ; pheochromocytoma )
secondary form of hypertension
secondary form of hypertension .
secondary hypertension
secondary hypertension of any aetiology ;
secondary hypertension of any etiology
secondary hypertension of any etiology .
secondary hypertension or malignant hypertension
secondary hypertension or severe hypertension
secondary hypertension or suspected of having secondary hypertension .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
secondary hypertension patients ; but not limited to the following diseases ( example : renovascular disease ; adrenal medullary and cortical hyperfunctions ; coarctation of the aorta ; hyperaldosteronism ; unilateral renal artery or bilateral renal artery stenosis ; cushing syndrome ; pheochromocytoma ; polycystic kidney disease ; etc ) .
severe / malignant / secondary hypertensive patients
severe / malignant / secondary hypertensive patients
severe / malignant / secondary hypertensive patients
severe hypertension ( > 200 / 110 mmhg ) or secondary hypertension
severe hypertension ( > 200 / 110 mmhg ) or secondary hypertension
severe hypertension ( > 200 / 110 mmhg ) or secondary hypertension
severe hypertension ( dbp > / = 110 mm hg or sbp > / = 180 mm hg ) or evidence of secondary forms of hypertension
severe hypertension ( dbp > / = 110 mm hg or sbp > / = 180 mm hg ) or evidence of secondary forms of hypertension
severe hypertension ( dbp > / = 110 mm hg or sbp > / = 180 mm hg ) or evidence of secondary forms of hypertension
severe hypertension ( dbp > / = 110 mm hg or sbp > / = 180 mm hg ) or evidence of secondary forms of hypertension
severe hypertension ; current diagnosis of heart failure ; history or evidence of a secondary form of hypertension ; participation in any investigational drug study within one month of planned participation ;
severe hypertension ; current diagnosis of heart failure ; history or evidence of a secondary form of hypertension ; participation in any investigational drug study within one month of planned participation ;
severe hypertension ; current diagnosis of heart failure ; history or evidence of a secondary form of hypertension ; participation in any investigational drug study within one month of planned participation ;
severe hypertension ; current diagnosis of heart failure ; history or evidence of a secondary form of hypertension ; participation in any investigational drug study within one month of planned participation ;
subjects with secondary hypertension of any aetiology such as renal disease ; phaeochromocytoma ; or cushing syndrome .
subjects with secondary hypertension of any aetiology such as renal disease ; phaeochromocytoma ; or cushing syndrome .
subjects with secondary hypertension of any aetiology such as renal disease ; phaeochromocytoma ; or cushing syndrome .
virulent hypertension and secondary hypertension
virulent hypertension and secondary hypertension
secondary hypertension or malignant hypertension
secondary hypertension or severe hypertension
secondary hypertension or severe hypertension
